Geneva, Switzerland, April 23, 2026-Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric ...
Participants are required to register in advance of the conference using the link provided below. Upon registering, each participant will be provided with Participant Dial-in numbers, and a unique ...
Good day, and thank you for standing by. Welcome to the Addex Therapeutics Full Year 2025 Financial Results and Corporate Update Conference Call and Webcast. [Operator Instructions] Please be advised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results